Home › Borstkanker › Texas › League City
Borstkanker klinische studies in League City, TX
12 studies voor Borstkanker zoeken deelnemers op locaties in en rond League City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
RekruterenFase 1
- NEXT Houston, Galveston · 23 mijl verwijderd
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- Tranquility Research, Webster · 3 mijl verwijderd
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruterenFase 3
- Tranquil Clinical Research, Webster · 3 mijl verwijderd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- UT MD Anderson - League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mijl verwijderd
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RekruterenFase 2
- Tranquil Clinical Research, Webster · 3 mijl verwijderd
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruterenFase 3
- MD Anderson League City, League City
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- MD Anderson League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mijl verwijderd
- University of Texas Medical Branch, Galveston · 23 mijl verwijderd
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
RekruterenObservatieonderzoek
- MD Anderson League City, Nassau Bay · 3 mijl verwijderd
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Rekruteren
- University of Texas Medical Branch at Galveston, TX, Galveston · 23 mijl verwijderd
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
RekruterenGezonde vrijwilligers welkom
- The University of Texas Medical Branch, Galveston, Galveston · 23 mijl verwijderd
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruterenObservatieonderzoek
- University of Texas Medical Branch, League City
- Texas Oncology - Webster, Webster · 3 mijl verwijderd
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in League City
- Niet-kleincellige longkanker15 studies
- Metastatische kanker7 studies
- Colitis ulcerosa6 studies
- Longkanker6 studies
- Colorectale kanker6 studies
- Kanker (alle vormen)5 studies
- Eierstokkanker5 studies
- Beroerte5 studies
- Blasenkanker4 studies
- Plaveiselcelcarcinoom van hoofd en hals4 studies
- Prostaatkanker4 studies
- Post-COVID-aandoeningen (Long COVID)3 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.